Medicine and Healthnpj Vaccines
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants
S. Vishwanath, G. W. Carnell, et al.
This groundbreaking research conducted by Sneha Vishwanath and colleagues introduces three novel spike-based antigens designed to combat evolving SARS-CoV-2 variants. The study reveals promising results in eliciting broad neutralizing antibodies, demonstrating the potential for these computationally derived antigens to enhance immunity against a spectrum of variants over two years.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Biology
Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2
D. Wang, J. Baudys, et al.
Medicine and Health
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
H. Liang, X. Nian, et al.
Medicine and Health
Simplifying glycan monitoring of complex antigens such as the SARS-CoV-2 spike to accelerate vaccine development
J. Sauvageau, I. Koyuturk, et al.
Veterinary Science
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
S. Vishwanath, G. W. Carnell, et al.
